Lakefront Biotherapeutics (LKFT) EPS (Basic) (2014 - 2026)
Lakefront Biotherapeutics (LKFT) reported EPS (Basic) of $0.05 for Q1 2026, up 109.45% year-over-year from $0.02 in Q1 2025, and down 98.15% quarter-over-quarter from $2.66 in Q4 2025.
Lakefront Biotherapeutics (LKFT) EPS (Basic) (2014 - 2026) Analysis & Trends
Lakefront Biotherapeutics (LKFT) has 13 years of EPS (Basic) data on file, last reported at $0.05 in Q1 2026.
- EPS (Basic) for Q1 2026 came in at $0.05, up 109.45% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.71 (up 100.11% YoY), and the FY2025 annual result was $5.67, up 373.66% from the prior year.
- EPS (Basic) slipped to $0.05 in Q1 2026 per LKFT's latest filing, from $2.66 in the prior quarter.
- Over five years, EPS (Basic) peaked at $64442.9 in Q1 2024 and troughed at -$21559.8 in Q3 2023.
- A 5-year average of $6745.0 and a median of $0.05 in 2026 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2023: EPS (Basic) plunged 1575.83% in 2022, then surged 127539216.15% in 2023.
- A 5-year view of EPS (Basic) shows it stood at -$3.15 in 2022, then soared by 175.83% to $2.39 in 2023, then tumbled by 96.4% to $0.09 in 2024, then surged by 2990.63% to $2.66 in 2025, then tumbled by 98.15% to $0.05 in 2026.
- Business Quant data shows LKFT's EPS (Basic) at $0.05 in Q1 2026, $2.66 in Q4 2025, and $0.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 3.06 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 0.00 |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 0.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | -0.06 |
| 10 | Lakefront Biotherapeutics | 9.64 Bn | 9.64 Bn | 1.97 Mn | 0.05 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.05 |
| Dec 31, 2025 | 2.66 |
| Sep 30, 2025 | 0.01 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | -0.52 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | -2,513.51 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 64,442.86 |
| Dec 31, 2023 | 2.39 |
| Sep 30, 2023 | -21,559.76 |
| Jun 30, 2023 | 2,786.05 |
| Mar 31, 2023 | 58,017.50 |
| Dec 31, 2022 | -3.15 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.19 |
| Jun 30, 2021 | -0.22 |
| Mar 31, 2021 | 158,571.43 |
| Dec 31, 2020 | -0.61 |
| Jun 30, 2020 | 1.92 Mn |